We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Partnership Links Flow Cytometry Instruments and Reagents

By LabMedica International staff writers
Posted on 25 May 2010
Print article
A partnership has been announced that will unite the manufacturer of a line of moderately priced bench-top flow cytometer systems with a major producer of flow cytometry research reagents.

Accuri Cytometers (Ann Arbor, MI, USA) makes a full-featured bench top cell-analysis system that provides powerful capabilities similar to industry-leading flow cytometers in a user-friendly format and at a fraction of the cost. The "C6 System” includes blue and red lasers, four color detectors and both forward and side scatter detectors plus software that the manufacturer says is so intuitive that customers typically have the instrument up and running within an hour of receiving it.

The other half of the partnership is eBioscience (San Diego, CA, USA) a privately held company that makes more than 11,000 innovative high quality cell analysis reagents. Their product list comprises an array of high performing solutions, such as fluorescent dyes and bead assay reagents that enable comprehensive analysis of cells and soluble factors in the areas of immunology and cell biology research.

The partnership is designed to offer researchers a better and more comprehensive solution for their flow cytometry needs, harnessing the cost-effectiveness, ease-of-use, performance capabilities, and accessibility of the Accuri C6 Flow Cytometer System with the market leading extensive line of high quality cytometer research reagents offered by eBioscience.

"We are pleased to partner with reagent leader eBioscience to offer our growing customer base a wide range of quality reagents optimized for their varied research needs,” said Jack Ball, chief commercial officer of Accuri. "The adoption of the Accuri C6 Flow Cytometer System by over 500 research labs for an increasing range of applications has brought the need for high quality reagents that work seamlessly with our systems to the fore. This marketing partnership allows Accuri to further deliver on our promise to our customers to offer an affordable, easy-to-use flow cytometer solution—now made even more accessible with the easy availability of a full range of quality research reagents.”

"We are delighted to partner with Accuri, the fastest growing supplier of flow cytometers, and welcome the opportunity to educate our customers about the advantages of having a flow cytometer in their research labs, along with the outstanding performance attributes and surprising accessibility of the Accuri C6 Flow Cytometer system,” said Tony Ward, vice president of commercial operations of eBioscience. "As part of our shared goal to make high performance cell analysis more accessible to researchers worldwide, this agreement will provide customers with an effective and comprehensive solution right out of the box.”

Related Links:
Accuri Cytometers
eBioscience


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Automated Blood Typing System
IH-500 NEXT
New
Gold Member
ANA & ENA Screening Assays
ANA and ENA Assays
New
Monkeypox Test
Monkeypox Virus Rapid Antibody Test

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more

Pathology

view channel
Image: The artificial intelligence models can personalize immune therapies in oncology patients (Photo courtesy of 123RF)

AI Tool Identifies Novel Genetic Signatures to Personalize Cancer Therapies

Lung cancer and bladder cancer are among the most commonly diagnosed cancers globally. Researchers have now developed artificial intelligence (AI) models designed to personalize immune therapies for oncology... Read more

Technology

view channel
Image: Schematic diagram of nanomaterial-based anti-epileptic drug concentration diagnostic technology (Photo courtesy of KRISS)

Nanomaterial-Based Diagnostic Technology Accurately Monitors Drug Therapy in Epilepsy Patients

Many patients with epilepsy take anti-epileptic drugs to control frequent seizures in their daily lives. To optimize treatment and avoid side effects from overdosing, it is crucial for patients to regularly... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.